Natural Products Insider is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Home>Regulatory>Claims

Prebiotin Tested in NIH/NIDDK Pilot Study with End Stage Renal Disease Patients

<p>The NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) Hemodialysis Novel Therapies (HDNT) Study Group has been conducting early phase studies of novel interventions with the long-term goal to test promising therapies in full-scale clinical trials.</p>
TAGS: Regulatory
Hide comments
account-default-image
user not logged in

More information about text formats

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish
Related
Developing appropriate substantiation for supplement claims.jpg
Developing appropriate substantiation for supplement claims
Jul 23, 2020
corona congress for web.jpg
Mercola rejects accusations in watchdog’s congressional testimony over COVID-19 claims
Jul 23, 2020
Inflammation claims can cause a lot of pain for dietary supplement manufacturers.jpg
Inflammation claims can cause a lot of pain for dietary supplement manufacturers
Jul 16, 2020
Products promoting energy boost are defined by nutritive value.jpg
Products promoting energy boost are defined by nutritive value
Jul 02, 2020